课题基金 / 基金详情

Microbial Metabolites Inhibiting Salmonella Carriage and Disease

Microbial Metabolites Inhibiting Salmonella Carriage and Disease
抑制沙门氏菌携带和疾病的微生物代谢物
批准号:
10645214
负责人:
CRAIG ALTIER
金额:
$38.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-06-14 至 2027-05-31

项目摘要

项目成果

CRAIG ALTIER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT Diffusible signal factors (DSFs), long-chain fatty acids with a characteristic cis-2 unsaturation, are produced and used by several genera of gram-negative bacteria as quorum-sensing signals. We have found that the DSF cis-2 hexadecenoic acid (c2-HDA) is extremely potent in inhibiting expression of Salmonella functions necessary for colonization of the intestine and have found this compound to be present in the murine large intestine. As no mammalian source of fatty acids harboring a 2-cis unsaturation has been described, these findings strongly suggest that constituents of the gut microbiota produce and excrete DSFs that inhibit Salmonella virulence. We hypothesize that Salmonella uses the signals of these bacteria to balance its virulence functions, essential but also costly to the fitness and survival of the invading bacteria, with colonization and proliferation of the Salmonella population. Gut microbial metabolites may therefore serve multiple coordinated purposes in pathogens, balancing virulence functions with those required for proliferation within a host and thus affecting pathogen survival in the gut by multiple means. Here we propose to: Aim 1: Use complementary approaches to identify bacteria of the human gut microbiome that produce inhibitory DSFs and characterize their products; Aim 2: Identify the constellation of functions regulated in Salmonella by DSFs and identify mechanisms of this control, and; Aim 3: Using established murine models of Salmonella infection, characterize the biological function and translational relevance of c2-HDA to understand its mechanism of action and to support the eventual development of novel therapeutics, such as live biotherapeutic products, for the control of human salmonellosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Microbial Metabolites Inhibiting Salmonella Carriage and Disease
  • 批准号:
    10512806
  • 项目类别:
  • 资助金额:
    $38.42万
  • 财政年份:
    2022
  • 负责人:
    CRAIG ALTIER
  • 依托单位:
Interspecies Bacterial Signaling to Regulate Salmonella Virulence
  • 批准号:
    10278208
  • 项目类别:
  • 资助金额:
    $39.05万
  • 财政年份:
    2021
  • 负责人:
    CRAIG ALTIER
  • 依托单位:
Interspecies Bacterial Signaling to Regulate Salmonella Virulence
  • 批准号:
    10409837
  • 项目类别:
  • 资助金额:
    $39.04万
  • 财政年份:
    2021
  • 负责人:
    CRAIG ALTIER
  • 依托单位:
Interspecies Bacterial Signaling to Regulate Salmonella Virulence
  • 批准号:
    10612043
  • 项目类别:
  • 资助金额:
    $39.04万
  • 财政年份:
    2021
  • 负责人:
    CRAIG ALTIER
  • 依托单位:
海外基金